Pfizer: Long-acting Growth Hormone (LAGH) Research (Global)

Aim: Projects that focus on LAGH research, specifically: • Morbidities in growth disorders • Novel strategies to evaluate and treat growth disorders • Comparison of clinical effects of daily vs LAGH • Comparative pathophysiology of daily vs LAGH • Innovative methods to evaluate levels of adherence of daily and LAGH treatment • Novel strategies to address unmet medical needs in short stature management which could be addressed with LAGH. Funding: up to $100K/year for 1 to 2 years. Anticipated: up to 2-3 grants.

https://pfe-pfizercom-prod.s3.amazonaws.com/GMG_2020-RD-G_Long-actingGrowthHormoneResearch.pdf